Advertisement

World Journal of Surgery

, Volume 32, Issue 7, pp 1374–1384 | Cite as

Follow-Up After Surgery for Benign Nodular Thyroid Disease: Evidence-Based Approach

  • Roy Phitayakorn
  • Christopher R. McHenryEmail author
Article

Abstract

Background

There is no consensus on what constitutes appropriate methodology and timing for follow-up of patients after surgery for benign nodular disease.

Methods

A systematic review of the medical literature using evidence-based criteria was used to address the following four issues: (1) How often should patients who have undergone thyroidectomy for the treatment of benign nodular goiter be followed, and what constitutes appropriate follow-up? (2) What is the most appropriate method for detecting recurrent nodular thyroid disease? (3) Does thyroid hormone administration prevent recurrent nodular thyroid disease? (4) Does iodine administration prevent recurrent nodular thyroid disease?

Results

Altogether, 742 articles were found in MEDLINE using a keyword search strategy; we then narrowed them to 23 articles. There were a total of four articles with Level I data, five articles with Level II data, one article with Level III data, and 13 articles with Level IV or retrospective data.

Conclusions

Based on the available data, it is our recommendation that patients undergoing thyroid lobectomy for benign nodular thyroid disease should be followed with an annual physical examination, neck ultrasonography, and serum thyroid-stimulating hormone (TSH) measurement. Patients undergoing total thyroidectomy should be followed with an annual physical examination and a serum TSH measurement. Routine thyroxine and/or iodine supplementation may be useful for preventing recurrence in patients from iodine-deficient regions.

Keywords

Goiter Thyroxine Thyroid Nodule Iodine Deficiency Thyroid Volume 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Matovinovic J (1983) Endemic goiter and cretinism at the dawn of the third millennium. Annu Rev Nutr 3:341–412PubMedCrossRefGoogle Scholar
  2. 2.
    Ezzat S, Sarti DA, Cain DR et al (1994) Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838–1840PubMedCrossRefGoogle Scholar
  3. 3.
    Daniels GH (1996) Thyroid nodules and nodular thyroids: a clinical overview. Compr Ther 22:239–250PubMedGoogle Scholar
  4. 4.
    Tan GH, Gharib H (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126:226–231PubMedGoogle Scholar
  5. 5.
    Deandrea M, Mormile A, Veglio M et al (2002) Fine-needle aspiration biopsy of the thyroid: comparison between thyroid palpation and ultrasonography. Endocr Pract 8:282–286PubMedGoogle Scholar
  6. 6.
    Mittendorf EA, McHenry CR (1999) Follow-up evaluation and clinical course of patients with benign nodular thyroid disease. Am Surg 65:653–657PubMedGoogle Scholar
  7. 7.
    Liu Q, Djuricin G, Prinz RA (1998) Total thyroidectomy for benign thyroid disease. Surgery 123:2–7PubMedGoogle Scholar
  8. 8.
    Snook KL, Stalberg PL, Sidhu SB et al (2007) Recurrence after total thyroidectomy for benign multinodular goiter. World J Surg 31:593–599PubMedCrossRefGoogle Scholar
  9. 9.
    Feldkamp J, Seppel T, Becker A et al (1997) Iodide or l-thyroxine to prevent recurrent goiter in an iodine-deficient area: prospective sonographic study. World J Surg 21:10–14PubMedCrossRefGoogle Scholar
  10. 10.
    Hegedüs L, Hansen JM, Veiergang D et al (1987) Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size? Br Med J (Clin Res Ed). 294:801–803Google Scholar
  11. 11.
    Gibelin H, Sierra M, Mothes D et al (2004) Risk factors for recurrent nodular goiter after thyroidectomy for benign disease: case-control study of 244 patients. World J Surg 28:1079–1082PubMedCrossRefGoogle Scholar
  12. 12.
    Berghout A, Wiersinga WM, Drexhage HA et al (1989) The long-term outcome of thyroidectomy for sporadic nontoxic goiter. Clin Endocrinol (Oxf) 31:193CrossRefGoogle Scholar
  13. 13.
    Bistrup C, Nielsen JD, Gregersen G et al (1994) Preventive effect of levothyroxine in patients operated for non toxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin Endocrinol (Oxf) 40:323–327CrossRefGoogle Scholar
  14. 14.
    Piraneo S, Vitri P, Galimberti A et al (1994) Recurrence of goitre after operation for euthyroid patients. Eur J Surg 160:351–356PubMedGoogle Scholar
  15. 15.
    Shaha AR, Raffaelli, Proye C et al (2004) Predictive factors for recurrence after thyroid lobectomy for unilateral nontoxic goiter in an endemic area: Results of a multivariate analysis. Surgery 136:1250–1251Google Scholar
  16. 16.
    Rios A, Rodriguez JM, Balsalobre MD et al (2005) Results of surgery for toxic multinodular goiter. Surg Today 35:901–906PubMedCrossRefGoogle Scholar
  17. 17.
    Olson SE, Starling J, Chen H (2007) Symptomatic benign multinodular goiter: unilateral or bilateral thyroidectomy? Surgery 142:458–461PubMedCrossRefGoogle Scholar
  18. 18.
    Geerdsen JP, Frolund L (1984) Recurrence of nontoxic goitre with and without postoperative thyroxine medication. Clin Endocrinol (Oxf) 21:529–533CrossRefGoogle Scholar
  19. 19.
    Berglund J, Bondesson L, Christensen SB et al (1990) Indications for thyroxine therapy after surgery for nontoxic benign goitre. Acta Chir Scand 156:433–438PubMedGoogle Scholar
  20. 20.
    Miccoli P, Antonelli A, Iacconi P et al (1993) Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: result at the third year of follow-up. Surgery 114:1097–1101PubMedGoogle Scholar
  21. 21.
    Rios A, Rodriguez JM, Galindo PJ et al (2005) Surgical treatment of multinodular goiter in young patients. Endocrine 27:245–252PubMedCrossRefGoogle Scholar
  22. 22.
    Sackett DL (1989) Rules of evidence and clinical recommendations on the use of anti-thrombotic agents. Chest 95:2S–4SPubMedCrossRefGoogle Scholar
  23. 23.
    Heinrich S, Schafer M, Rousson V et al (2006) Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 243:154–168PubMedCrossRefGoogle Scholar
  24. 24.
    Geerdsen JP, Frolund R (1986) Thyroid function after surgical treatment of non toxic goiter. A randomized study of postoperative thyroxine administration. Acta Med Scand 220:341–345PubMedCrossRefGoogle Scholar
  25. 25.
    Date J, Feldt-Rasmussen U, Blichert-Toft M et al (1996) Long-term observation of serum thyroglobulin after resection of nontoxic goiter and relation to ultrasonographically demonstrated relapse. World J Surg 20:351–356PubMedCrossRefGoogle Scholar
  26. 26.
    Hegedus L, Perrild H, Poulsen LR et al (1983) The determination of thyroid volume by US and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 56:260–263PubMedGoogle Scholar
  27. 27.
    Mortenson JD, Woolner LB, Bennett WA (1955) Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270–1280CrossRefGoogle Scholar
  28. 28.
    Tannahill AJ, Hooper MJ, England M et al (1978) Measurement of thyroid size by US, palpation and scintiscan. Clin Endocrinol (Oxf) 8:483–486CrossRefGoogle Scholar
  29. 29.
    Hegedüs L, Bonnema SJ, Bennedbaek FN (2003) Management of simple nodular goiter: Current status and future perspectives. Endocr Rev 24:102–132PubMedCrossRefGoogle Scholar
  30. 30.
    Marqusee E, Benson CB, Frates MC et al (2000) Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 133:696–700PubMedGoogle Scholar
  31. 31.
    Cesur M, Corapcioglu D, Bulut S et al (2006) Comparison of palpation-guided fine-needle aspiration biopsy to US-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules. Thyroid 16:555–561PubMedCrossRefGoogle Scholar
  32. 32.
    Izquierdo R, Arekat MR, Knudson PE et al (2006) Comparison of palpation-guided versus US-guided fine-needle aspiration biopsies of thyroid nodules in an outpatient endocrinology practice. Endocr Pract 12:609–614PubMedGoogle Scholar
  33. 33.
    Brander A, Viikinkoski P, Tuuhea J et al (1992) Clinical versus US examination of the thyroid gland in common clinical practice. J Clin US 20:37–42CrossRefGoogle Scholar
  34. 34.
    Schneider AB, Bekerman C, Leland J et al (1997) Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid US with scanning and palpation. J Clin Endocrinol Metab 82:4020–4027PubMedCrossRefGoogle Scholar
  35. 35.
    Wiest PW, Hartshorne MF, Inskip PD et al (1998) Thyroid palpation versus high-resolution thyroid ultrasonography in the detection of nodules. J US Med 17:487–496Google Scholar
  36. 36.
    Knudsen N, Bols B, Bulow I et al (1999) Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 9:1069–1074PubMedGoogle Scholar
  37. 37.
    Miccoli P, Minuto MN, Orlandini C et al (2006) Ultrasonography estimated thyroid volume: a prospective study about its reliability. Thyroid 16:37–39PubMedCrossRefGoogle Scholar
  38. 38.
    Schlogl S, Werner E, Lassmann M et al (2001) The use of three-dimensional US for thyroid volumetry. Thyroid 11:569–574PubMedCrossRefGoogle Scholar
  39. 39.
    Brauer VF, Eder P, Miehle K et al (2005) Inter-observer variation for US determination of thyroid nodule volumes. Thyroid 15:1169–1175PubMedCrossRefGoogle Scholar
  40. 40.
    Tamsel S, Demirpolat G, Erdogan M et al (2007) Power Doppler US patterns of vascularity and spectral Doppler US parameters in predicting malignancy in thyroid nodules. Clin Radiol 62:245–251PubMedCrossRefGoogle Scholar
  41. 41.
    Shimura H, Haraguchi K, Hiejima Y et al (2005) Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: a multicenter study. Thyroid 15:251–258PubMedCrossRefGoogle Scholar
  42. 42.
    Koike E, Noguchi S, Yamashita H et al (2001) Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg 136:334–337PubMedCrossRefGoogle Scholar
  43. 43.
    Rago T, Santini F, Scutari M et al (2007) Elastography: new developments in US for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab 92:2917–2922PubMedCrossRefGoogle Scholar
  44. 44.
    Kim EK, Park CS, Chung WY et al (2002) New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol 178:687–691PubMedGoogle Scholar
  45. 45.
    Wang N, Xu Y, Ge C et al (2006) Association of sonographically detected calcification with thyroid carcinoma. Head Neck 28:1077–1083PubMedCrossRefGoogle Scholar
  46. 46.
    Alexander EK, Marqusee E, Orcutt J et al (2004) Thyroid nodule shape and prediction of malignancy. Thyroid 14:953–958PubMedCrossRefGoogle Scholar
  47. 47.
    Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142PubMedGoogle Scholar
  48. 48.
    AACE/AME Task Force on Thyroid Nodules (2006) American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 39:63–102Google Scholar
  49. 49.
    Moon HG, Jung EJ, Park ST et al (2007) Role of ultrasonography in predicting malignancy in patients with thyroid nodules. World J Surg 31:1410–1416PubMedCrossRefGoogle Scholar
  50. 50.
    Kopp P, Kimura ET, Aeschimann S et al (1994) Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab 79:134–139PubMedCrossRefGoogle Scholar
  51. 51.
    Persson CP, Johansson H, Westermark K et al (1982) Nodular goiter: is thyroxine medication of any value? World J Surg 6:391–396PubMedCrossRefGoogle Scholar
  52. 52.
    Hedman I, Jansson S, Lindberg S (1986) Need for thyroxine in patients lobectomized for benign thyroid disease as assessed by follow up on average fifteen years after surgery. Acta Chir Scand 152:481–486PubMedGoogle Scholar
  53. 53.
    Anderson PE, Hurley PR, Rosswick P (1990) Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter. Surg Gynecol Obstet 171:309–314PubMedGoogle Scholar
  54. 54.
    Ibis E, Erbay G, Aras G et al (1991) Postoperative goitre recurrence rate in Turkey. Acta Endocrinol (Copenh) 125:33–37Google Scholar
  55. 55.
    Rojdmark J, Jarhult J (1995) High long term recurrence rate after subtotal thyroidectomy for nodular goiter. Eur J Surg 161:725–727PubMedGoogle Scholar
  56. 56.
    Teuscher J, Peter H, Gerber HJ et al (1988) Pathogenesis of nodular goitre and its application for surgical treatment. Surgery 103:87–93PubMedGoogle Scholar
  57. 57.
    Torre G, Barreca A, Borgonovo G et al (2000) Goiter recurrence in patients submitted to thyroid-stimulating hormone suppression: possible role of insulin-like growth factors and insulin-like growth factor-binding proteins. Surgery 127:99–103PubMedCrossRefGoogle Scholar
  58. 58.
    Carella C, Mazziotti G, Rotondi M et al (2002) Iodized salt improves the effectiveness of l-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study. Clin Endocrinol (Oxf) 57:507–513CrossRefGoogle Scholar
  59. 59.
    Brabant G, Bergmann P, Kirsch CM et al (1992) Early adaptation of thyrotropin and thyroglobulin secretion to experimentally decreased iodine supply in man. Metabolism 41:1093–1096PubMedCrossRefGoogle Scholar
  60. 60.
    Stubner D, Gartner R, Greil W et al (1987) Hypertrophy and hyperplasia during goitre growth and involution in rats: separate bioeffects of TSH and iodine. Acta Endocrinol (Copenh) 116:537–548Google Scholar
  61. 61.
    Einenkel D, Bauch KH, Benker G (1992) Treatment of juvenile goitre with levothyroxine, iodide or a combination of both: the value of US grey-scale analysis. Acta Endocrinol (Copenh) 27:301–306Google Scholar
  62. 62.
    Hintze G, Emrich D, Kobberling J (1989) Treatment of endemic goitre due to iodine deficiency with iodine, levothyroxine or both: results of a multicentre trial. Eur J Clin Invest 19:527–534PubMedCrossRefGoogle Scholar
  63. 63.
    White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895–904PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2008

Authors and Affiliations

  1. 1.Department of SurgeryMetroHealth Medical Center, Case Western Reserve University School of MedicineClevelandUSA

Personalised recommendations